secwatch.observer — SEC 8-K summary
======================================

Issuer:     MYRIAD GENETICS INC (MYGN)
CIK:        0000899923
Form:       8-K
Filed at:   2022-04-01T23:59:59+00:00
Accession:  0000899923-22-000036
Event type: litigation
Sentiment:  neutral
Materiality: 0.70
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Myriad Genetics settles Vectra test qui tam case for $48M ($45.25M to govt, $2.75M to relator)
--------------------------------------------------------------------------------

- Total settlement of $48 million: $45.25M to United States and California, $2.75M to Relator's counsel.
- No admission of liability; company expressly denies allegations in the lawsuit.
- DOJ and State of California declined to intervene after investigation.
- Lawsuit dismissed with prejudice as to Relator and California; federal claims dismissed without prejudice.
- Settlement resolves claims concerning Crescendo's former Vectra test dating back to 2010.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/899923/000089992322000036/0000899923-22-000036-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/899923/000089992322000036/mygn-20220401.htm
  HTML page:      https://secwatch.observer/filing/0000899923-22-000036

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer